BRIGATINIB

1937 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking BRIGATINIB:

# Side effect Count
0 DEATH 252
1 NON-SMALL CELL LUNG CANCER 195
2 NEOPLASM PROGRESSION 168
3 OFF LABEL USE 144
4 DIARRHOEA 127
5 NAUSEA 121
6 FATIGUE 120
7 METASTASES TO CENTRAL NERVOUS SYSTEM 118
8 DRUG INEFFECTIVE 103
9 BLOOD CREATINE PHOSPHOKINASE INCREASED 89
See all common reactions for BRIGATINIB

BRIGATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRAIN STENT INSERTION 1 0.1429
1 MAGNETIC RESONANCE IMAGING THORACIC ABNORMAL 1 0.1111
2 ANAPLASTIC LYMPHOMA KINASE GENE MUTATION 4 0.0870
3 ACID PEPTIC DISEASE 1 0.0769
4 PITUITARY INFARCTION 3 0.0750
5 NON-SMALL CELL LUNG CANCER 195 0.0668
6 MALIGNANT CONNECTIVE TISSUE NEOPLASM 1 0.0625
7 MALIGNANT NERVOUS SYSTEM NEOPLASM 2 0.0571
8 ANTI FACTOR X ACTIVITY INCREASED 2 0.0526
9 NON-SMALL CELL LUNG CANCER STAGE IIIA 1 0.0400
See all enriched reactions for BRIGATINIB